BIOMEDICINE & PHARMACOTHERAPY

Journal Title
BIOMEDICINE & PHARMACOTHERAPY

BIOMED PHARMACOTHER

ISSN / eISSN
0753-3322
Aims and Scope
Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.

The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.

Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.

Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers
Subject Area

PHARMACOLOGY & PHARMACY

MEDICINE, RESEARCH & EXPERIMENTAL

CiteScore
12.60 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #18/301
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE Q1
PHARMACOLOGY & PHARMACY - SCIE Q1
H-index
78
Country/Area of Publication
FRANCE
Publisher
Elsevier Masson
Publication Frequency
Monthly
Year Publication Started
1982
Annual Article Volume
1446
Open Access
NO
Contact
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
An article combining bioinformatics and experiments

(I previously submitted it to Frontiers in Genetics, but the reviewer's rejection comments were very biased.)

Submitted on December 2, 2020
Revised on December 27, 2020, with the main suggestions being to provide code, experimental details and supplementary attachments, graphical abstract, and an open discussion (very gentle)

Uploaded revised files on January 21, 2021

Accepted on January 31, 2021, and the reviewer was very satisfied

Sent an email on February 19, 2021, asking about the proofreading timeline, and received a reply stating it would be revised within two working days

Originally thought it would be a Tier 3 journal, but surprisingly it was accepted in Tier 2. Hoping to make use of this article as soon as possible in 2021.

The only regret is that the journal warning list from the Chinese Academy of Sciences was not released when I submitted it.
2021-02-19
Overall, this magazine is quite good. I would like to share my submission experience.
I submitted on January 4th and a week later, they requested the WB original tapes to be supplemented (the result needs to be repeated three times, otherwise it will not be reviewed). After uploading the WB original tapes on January 14th, it was sent for external review on January 15th.
On January 28th, I received comments from two reviewers, both requiring minor revisions and the production of graphical abstracts, with a deadline of 20 days.
I uploaded the revised manuscript on February 14th at noon, and it was accepted on February 15th in the early morning.
Overall, the magazine's review speed is very fast. The magazine has high requirements for details.
2022-03-06

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started